ORTHO CLINICAL DIAGNOSTICS H (OCDX) Stock Cash Flow
NASDAQ:OCDX - Nasdaq - GB00BMDNH979 - Common Stock
| TTM (2022-4-3) | 2021 (2022-1-2) | 2020 (2021-1-3) | 2019 (2019-12-29) | 2018 (2018-12-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -400.00K | -54.30M | -211.90M | -156.90M | -248.80M | |||
| Depreciation Amortization | 324.80M | 328.10M | 325.90M | 327.50M | 332.20M | |||
| Income Taxes - Deferred | 2.40M | 4.20M | -2.50M | -4.40M | -4.70M | |||
| Change In Working Capital | -23.90M | -47.90M | -168.80M | -56.50M | -84.80M | |||
| Interest Paid | N/A | 132.10M | 191.80M | 189.70M | 218.80M | |||
| Taxes Paid | N/A | 22.20M | 16.80M | 8.40M | 13.40M | |||
| Other non cash items | -10.40M | 56.50M | 103.40M | 33.30M | 75.70M | |||
| OPERATING CASH FLOW | 292.50M | 286.60M | 46.10M | 143.00M | 69.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -72.00M | -58.40M | -44.10M | -66.20M | -79.20M | |||
| Other Investing Activity | 11.90M | 14.80M | -1.30M | -2.30M | -7.90M | |||
| INVESTING CASH FLOW | -60.10M | -43.60M | -45.40M | -68.50M | -87.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -125.00M | -1.50B | 54.00M | -64.10M | -7.90M | |||
| Stock Issued/Repurchased | 15.50M | 1.44B | 1.80M | -300.00K | -300.00K | |||
| Other Financing Activity | N/A | -9.20M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -113.70M | -74.70M | 55.80M | -64.40M | -8.20M | |||
| Exchange Rate Effect | -200.00K | -900.00K | 3.70M | -700.00K | -4.30M | |||
| CHANGE IN CASH | 118.50M | 167.40M | 60.20M | 9.40M | -30.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 292.50M | 286.60M | 46.10M | 143.00M | 69.60M | |||
| Capital Expenditure | -72.00M | -58.40M | -44.10M | -66.20M | -79.20M | |||
| FREE CASH FLOW | 220.50M | 228.20M | 2.00M | 76.80M | -9.60M | |||
All data in USD